
Federal regulators have formally approved Capital One Financial’s $35.3 billion all-stock acquisition of Discover Financial Services.
The Federal Reserve and the Office of the Comptroller of the Currency (OCC) announced the decision Friday, signaling the green light for one of the most significant banking mergers in recent years.
According to CNBC, the Federal Reserve evaluated the merger based on several legal and financial criteria, including the financial strength of both institutions, the managerial capacity of the combined entity, the expected impact on communities, and how the transaction could affect industry competition and financial stability.
Initially announced in February 2024, the acquisition includes Discover Bank and positions Capital One to significantly bolster its footprint in the consumer finance space. Under the terms of the agreement, Discover shareholders will receive 1.0192 shares of Capital One for each Discover share—a premium of roughly 26% based on Discover’s share price at the time of the announcement, per CNBC.
Read more: Capital One/Discover Deal: Rumored Concerns Lack Substance
Both Capital One and Discover rank among the country’s largest credit card issuers. The merger is expected to not only broaden Capital One’s deposit base but also enhance its credit card portfolio and consumer lending capabilities. Once the deal is finalized, Capital One shareholders will hold 60% of the newly formed company, while Discover shareholders will control the remaining 40%.
In a joint statement, the two companies reaffirmed that the transaction is on track to close on May 18, barring any unexpected developments.
Source: CNBC
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas